CONMED Financial Statements From 2010 to 2024

CNMD Stock  USD 74.91  3.20  4.46%   
CONMED financial statements provide useful quarterly and yearly information to potential CONMED investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CONMED financial statements helps investors assess CONMED's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CONMED's valuation are summarized below:
Gross Profit
575.7 M
Profit Margin
0.1023
Market Capitalization
2.3 B
Enterprise Value Revenue
2.497
Revenue
1.3 B
There are over one hundred nineteen available fundamental signals for CONMED, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of CONMED's prevailing performance against the performance from 2010 to 2024 to make sure the company is sustainable for few more years. The current year's Market Cap is expected to grow to about 3.9 B. The current year's Enterprise Value is expected to grow to about 819.6 M

CONMED Total Revenue

1.3 Billion

Check CONMED financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CONMED's main balance sheet or income statement drivers, such as Depreciation And Amortization of 31.9 M, Interest Expense of 41.8 M or Selling General Administrative of 531.1 M, as well as many indicators such as Price To Sales Ratio of 2.84, Dividend Yield of 0.0136 or PTB Ratio of 4.23. CONMED financial statements analysis is a perfect complement when working with CONMED Valuation or Volatility modules.
  
Check out the analysis of CONMED Correlation against competitors.
For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

CONMED Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.4 B2.3 B1.4 B
Slightly volatile
Short and Long Term Debt TotalB991.3 M519.5 M
Slightly volatile
Other Current Liabilities233.6 M222.5 M101.3 M
Slightly volatile
Total Current Liabilities326.3 M310.7 M169 M
Slightly volatile
Total Stockholder Equity428.2 M834.2 M602.9 M
Slightly volatile
Property Plant And Equipment Net92.9 M137.3 M114.5 M
Pretty Stable
Net DebtB967 M487.1 M
Slightly volatile
Retained Earnings246.1 M452.5 M386.7 M
Slightly volatile
Cash17.2 M24.3 M31 M
Pretty Stable
Non Current Assets Total1.8 B1.7 BB
Slightly volatile
Non Currrent Assets Other83.5 M79.5 M61.9 M
Slightly volatile
Cash And Short Term Investments17.5 M24.3 M31 M
Pretty Stable
Net Receivables254.4 M242.3 M161.3 M
Slightly volatile
Common Stock Shares Outstanding25.9 M31.5 M27.4 M
Slightly volatile
Liabilities And Stockholders Equity2.4 B2.3 B1.4 B
Slightly volatile
Non Current Liabilities Total1.2 B1.2 B644.2 M
Slightly volatile
Inventory334.2 M318.3 M186.2 M
Slightly volatile
Other Current Assets32.3 M30.8 M20.5 M
Slightly volatile
Other Stockholder Equity453.1 M431.5 M275 M
Slightly volatile
Total Liabilities1.5 B1.5 B813.2 M
Slightly volatile
Property Plant And Equipment Gross433.5 M412.9 M191.5 M
Slightly volatile
Total Current Assets646.4 M615.6 M402.9 M
Slightly volatile
Short Term Debt16.8 M16.4 M17.2 M
Slightly volatile
Intangible Assets331.7 M649.5 M383.3 M
Slightly volatile
Accounts Payable92.6 M88.2 M46 M
Slightly volatile
Good Will430.8 M806.8 M427 M
Slightly volatile
Common Stock Total Equity317.6 K359.9 K302.2 K
Slightly volatile
Common Stock342 K359.9 K63.2 M
Slightly volatile
Other Liabilities312.3 M297.5 M127 M
Slightly volatile
Other Assets103.6 M98.7 M66.4 M
Slightly volatile
Long Term DebtB973.1 M523.8 M
Slightly volatile
Property Plant Equipment129.3 M133 M120.5 M
Very volatile
Retained Earnings Total Equity467.3 M474.5 M426.3 M
Slightly volatile
Long Term Debt Total1.2 B1.1 B528.8 M
Slightly volatile
Capital Surpluse384.5 M475.2 M358.4 M
Slightly volatile
Deferred Long Term Liabilities72.4 M60.1 M87.4 M
Slightly volatile
Non Current Liabilities Other68.4 M121 M61.8 M
Slightly volatile
Deferred Long Term Asset Charges5.7 M5.4 M3.5 M
Slightly volatile
Short and Long Term Debt672.6 K708 K11.1 M
Slightly volatile
Net Invested Capital1.6 B1.8 B1.3 B
Slightly volatile
Net Working Capital268.6 M304.9 M228.3 M
Slightly volatile
Capital Stock250.4 K281.7 K306.7 K
Slightly volatile
Capital Lease Obligations19.2 M20.5 M24 M
Slightly volatile

CONMED Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization31.9 M51.4 M47.3 M
Slightly volatile
Selling General Administrative531.1 M505.8 M347.8 M
Slightly volatile
Total Revenue1.3 B1.2 B836.7 M
Slightly volatile
Gross Profit675.2 M643.1 M448.2 M
Slightly volatile
Other Operating Expenses1.2 B1.1 B768.4 M
Slightly volatile
EBITDA191.3 M182.2 M105.2 M
Slightly volatile
Cost Of Revenue627.8 M597.9 M388.5 M
Slightly volatile
Total Operating Expenses592.5 M564.2 M387 M
Slightly volatile
Research Development28.4 M52.6 M33.6 M
Slightly volatile
Non Recurring48.2 M54.3 M59.1 M
Slightly volatile
Interest Income51.6 M49.1 M24.1 M
Slightly volatile
Reconciled Depreciation75 M71.6 M64.1 M
Slightly volatile
Extraordinary Items769.5 K810 K17.4 M
Slightly volatile
Selling And Marketing Expenses299.1 M336.4 M366.3 M
Slightly volatile

CONMED Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow111.6 M106.3 M59.3 M
Slightly volatile
Begin Period Cash Flow18.1 M28.9 M30.3 M
Very volatile
Depreciation37.5 M51.4 M51.9 M
Slightly volatile
Other Non Cash Items19.2 M24.1 M36.8 M
Pretty Stable
Capital Expenditures17.6 M19 M16.4 M
Pretty Stable
Total Cash From Operating Activities131.6 M125.3 M75.9 M
Slightly volatile
Dividends Paid18.7 M24.5 M23.1 M
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.842.70632.136
Slightly volatile
Dividend Yield0.01360.00730.013
Slightly volatile
PTB Ratio4.234.02592.8324
Slightly volatile
Days Sales Outstanding74.9271.261270.3336
Slightly volatile
Book Value Per Share28.5627.201722.2409
Slightly volatile
Free Cash Flow Yield0.03010.03170.0516
Slightly volatile
Operating Cash Flow Per Share4.294.08732.6652
Slightly volatile
Stock Based Compensation To Revenue0.02050.01950.0126
Slightly volatile
Capex To Depreciation0.350.37030.3369
Slightly volatile
PB Ratio4.234.02592.8324
Slightly volatile
EV To Sales3.663.48562.6504
Slightly volatile
Free Cash Flow Per Share3.643.46672.0844
Slightly volatile
Inventory Turnover2.481.87822.324
Slightly volatile
Days Of Inventory On Hand137194163
Slightly volatile
Payables Turnover13.16.776911.0287
Slightly volatile
Sales General And Administrative To Revenue0.280.380.396
Very volatile
Research And Ddevelopement To Revenue0.0310.04240.0405
Slightly volatile
Capex To Revenue0.01460.01530.0208
Slightly volatile
Cash Per Share0.480.79221.1087
Pretty Stable
POCF Ratio13.5526.79326.3591
Slightly volatile
Capex To Operating Cash Flow0.140.15180.2515
Very volatile
PFCF Ratio33.1731.589343.7668
Slightly volatile
Days Payables Outstanding27.753.859338.0174
Slightly volatile
EV To Operating Cash Flow18.334.507233.3915
Slightly volatile
EV To Free Cash Flow42.7240.684556.4757
Slightly volatile
Intangibles To Total Assets0.40.63320.5406
Slightly volatile
Net Debt To EBITDA5.15.307512.0664
Slightly volatile
Current Ratio1.881.98132.5599
Slightly volatile
Receivables Turnover4.535.1225.1826
Slightly volatile
Graham Number37.6635.866524.5358
Slightly volatile
Shareholders Equity Per Share28.5627.201722.2409
Slightly volatile
Debt To Equity1.231.17440.7414
Slightly volatile
Capex Per Share0.50.62060.5707
Very volatile
Revenue Per Share42.4940.464129.4001
Slightly volatile
Interest Debt Per Share34.933.242318.5273
Slightly volatile
Debt To Assets0.240.4260.3038
Slightly volatile
Enterprise Value Over EBITDA19.1623.741749.0989
Slightly volatile
Short Term Coverage Ratios11.7415.254721.0132
Slightly volatile
Operating Cycle191266232
Slightly volatile
Price Book Value Ratio4.234.02592.8324
Slightly volatile
Days Of Payables Outstanding27.753.859338.0174
Slightly volatile
Price To Operating Cash Flows Ratio13.5526.79326.3591
Slightly volatile
Price To Free Cash Flows Ratio33.1731.589343.7668
Slightly volatile
Company Equity Multiplier1.612.75712.1082
Slightly volatile
Long Term Debt To Capitalization0.280.5380.3671
Slightly volatile
Total Debt To Capitalization0.290.54010.3789
Slightly volatile
Debt Equity Ratio1.231.17440.7414
Slightly volatile
Quick Ratio0.910.95691.4434
Slightly volatile
Dividend Paid And Capex Coverage Ratio2.852.87932.3239
Slightly volatile
Cash Ratio0.07430.07820.2411
Slightly volatile
Cash Conversion Cycle229212198
Slightly volatile
Operating Cash Flow Sales Ratio0.110.1010.0928
Slightly volatile
Days Of Inventory Outstanding137194163
Slightly volatile
Days Of Sales Outstanding74.9271.261270.3336
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.890.84820.7505
Very volatile
Cash Flow Coverage Ratios0.120.12790.2693
Slightly volatile
Price To Book Ratio4.234.02592.8324
Slightly volatile
Fixed Asset Turnover9.499.03646.9992
Slightly volatile
Capital Expenditure Coverage Ratio6.926.58624.6153
Slightly volatile
Price Cash Flow Ratio13.5526.79326.3591
Slightly volatile
Enterprise Value Multiple19.1623.741749.0989
Slightly volatile
Debt Ratio0.240.4260.3038
Slightly volatile
Cash Flow To Debt Ratio0.120.12790.2693
Slightly volatile
Price Sales Ratio2.842.70632.136
Slightly volatile
Asset Turnover0.830.53950.6568
Slightly volatile
Gross Profit Margin0.420.51820.5278
Pretty Stable
Price Fair Value4.234.02592.8324
Slightly volatile

CONMED Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.9 B3.7 B3.8 B
Slightly volatile
Enterprise Value819.6 M780.6 M802.7 M
Slightly volatile

CONMED Fundamental Market Drivers

Forward Price Earnings27.027
Cash And Short Term Investments24.3 M

CONMED Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About CONMED Financial Statements

CONMED stakeholders use historical fundamental indicators, such as CONMED's revenue or net income, to determine how well the company is positioned to perform in the future. Although CONMED investors may analyze each financial statement separately, they are all interrelated. For example, changes in CONMED's assets and liabilities are reflected in the revenues and expenses on CONMED's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CONMED. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-8.2 M-7.8 M
Total Revenue1.2 B1.3 B
Cost Of Revenue597.9 M627.8 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.38  0.28 
Research And Ddevelopement To Revenue 0.04  0.03 
Capex To Revenue 0.02  0.01 
Revenue Per Share 40.46  42.49 
Ebit Per Revenue 0.11  0.11 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CONMED is a strong investment it is important to analyze CONMED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CONMED's future performance. For an informed investment choice regarding CONMED Stock, refer to the following important reports:
Check out the analysis of CONMED Correlation against competitors.
For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.14
Dividend Share
0.8
Earnings Share
4.22
Revenue Per Share
41.821
Quarterly Revenue Growth
0.04
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.